Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

ClinicalTrials.gov ID: NCT00314210

Public ClinicalTrials.gov record NCT00314210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 8:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Centre,Double-Blind,Randomised-Withdrawal,Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine SR as Monotherapy in the Maintenance Treatment of Patients With GAD Following an Open-Label Stabilisation Period

Study identification

NCT ID
NCT00314210
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
575 participants

Conditions and interventions

Interventions

  • Quetiapine SR Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2006
Primary completion
Not listed
Completion
Jul 31, 2007
Last update posted
Mar 24, 2009

2006 – 2007

United States locations

U.S. sites
56
U.S. states
23
U.S. cities
56
Facility City State ZIP Site status
Research Site Mesa Arizona
Research Site Peoria Arizona
Research Site Phoenix Arizona
Research Site Fresno California
Research Site La Mesa California
Research Site Oceanside California
Research Site Redlands California
Research Site Coral Springs Florida
Research Site DeLand Florida
Research Site Fort Myers Florida
Research Site Gainsville Florida
Research Site Hialeah Florida
Research Site Jacksonville Florida
Research Site North Miami Florida
Research Site Orlando Florida
Research Site Saint Petersberg Florida
Research Site Atlanta Georgia
Research Site Columbus Georgia
Research Site Marietta Georgia
Research Site Roswell Georgia
Research Site Coeur d'Alene Idaho
Research Site Hoffman Estates Illinois
Research Site Libertyville Illinois
Research Site Indianapolis Indiana
Research Site Lafayette Indiana
Research Site Valparaiso Indiana
Research Site Prairie Village Kansas
Research Site Owensboro Kentucky
Research Site Paducah Kentucky
Research Site Shreveport Louisiana
Research Site Glen Burnie Maryland
Research Site Boston Massachusetts
Research Site Cambridge Massachusetts
Research Site Pittsfield Massachusetts
Research Site Saint Charles Missouri
Research Site Piscataway New Jersey
Research Site Cedarhurst New York
Research Site New York New York
Research Site Rochester New York
Research Site The Bronx New York
Research Site Avon Lake Ohio
Research Site Beechwood Ohio
Research Site Cincinnati Ohio
Research SIte Middleburg Heights Ohio
Research Site Toledo Ohio
Research Site Oklahoma City Oklahoma
Research Site Allentown Pennsylvania
Research Site Havertown Pennsylvania
Research Site Pittsburgh Pennsylvania
Research Site North Charleston South Carolina
Research Site Memphis Tennessee
Research Site DeSoto Texas
Research Site San Antonio Texas
Research Site Wichita Falls Texas
Research Site Midvale Utah
Research Site Richmond Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00314210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2009 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00314210 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →